Maury Raycroft
Stock Analyst at Jefferies
(4.43)
# 1,162
Out of 4,520 analysts
231
Total ratings
43.7%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ERAS Erasca | Rated: Buy | $21 → $24 | $19.17 | +25.20% | 3 | Jul 14, 2026 | |
| COAG Hemab Therapeutics Holdings | Maintained: Buy | $39 → $47 | $49.29 | -4.65% | 3 | Jul 13, 2026 | |
| TNGX Tango Therapeutics | Upgraded: Buy | $27 → $60 | $28.56 | +110.08% | 3 | Jun 26, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $132 | $105.60 | +25.00% | 6 | Jun 15, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintained: Buy | $53 → $33 | $9.01 | +266.26% | 7 | May 12, 2026 | |
| BCYC Bicycle Therapeutics | Maintained: Buy | $12 | $4.21 | +185.04% | 1 | Apr 30, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $8 → $9 | $2.05 | +339.02% | 4 | Apr 27, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $14 → $52 | $36.01 | +44.40% | 2 | Apr 5, 2026 | |
| KOD Kodiak Sciences | Rated: Buy | $39 → $56 | $42.64 | +31.33% | 4 | Mar 26, 2026 | |
| VALN Valneva SE | Maintained: Buy | $14 → $15 | $5.00 | +200.00% | 7 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $1.82 | +1,438.46% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $20 | $4.61 | +333.84% | 5 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $21 | $15.96 | +31.58% | 16 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $2 → $1.6 | $1.19 | +34.45% | 4 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $384 → $549 | $267.47 | +105.26% | 35 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $15 | $9.29 | +61.46% | 13 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $41 | $27.53 | +48.93% | 1 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $35 | $56.71 | -38.28% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $79 | $88.38 | -10.61% | 3 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $23 | $10.73 | +114.35% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $3.5 | $0.88 | n/a | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $5.96 | n/a | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $9 | $3.13 | n/a | 2 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $15 | $8.72 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $1.5 | $0.065 | n/a | 8 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7 | $0.3101 | n/a | 1 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $1.24 | n/a | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $31 | $32.13 | n/a | 5 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $129 | $29.28 | n/a | 14 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $20 | $0.000001 | n/a | 5 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $31.16 | n/a | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.966 | n/a | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 → $26 | $38.50 | n/a | 5 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $74.30 | n/a | 7 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 → $159 | $47.78 | n/a | 6 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $5 | $1.29 | n/a | 4 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $109 | $11.38 | n/a | 7 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $25 | $8.39 | n/a | 11 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $86 | $20.20 | n/a | 2 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $35 | $9.51 | n/a | 6 | Jun 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $7.87 | n/a | 2 | May 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $1.79 | n/a | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $16 | $68.26 | n/a | 6 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $7.00 | n/a | 2 | May 22, 2018 |
Erasca
Jul 14, 2026
Rated: Buy
Price Target: $21 → $24
Current: $19.17
Upside: +25.20%
Hemab Therapeutics Holdings
Jul 13, 2026
Maintained: Buy
Price Target: $39 → $47
Current: $49.29
Upside: -4.65%
Tango Therapeutics
Jun 26, 2026
Upgraded: Buy
Price Target: $27 → $60
Current: $28.56
Upside: +110.08%
Dianthus Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $132
Current: $105.60
Upside: +25.00%
Corbus Pharmaceuticals Holdings
May 12, 2026
Maintained: Buy
Price Target: $53 → $33
Current: $9.01
Upside: +266.26%
Bicycle Therapeutics
Apr 30, 2026
Maintained: Buy
Price Target: $12
Current: $4.21
Upside: +185.04%
Compass Therapeutics
Apr 27, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $2.05
Upside: +339.02%
IDEAYA Biosciences
Apr 5, 2026
Maintained: Buy
Price Target: $14 → $52
Current: $36.01
Upside: +44.40%
Kodiak Sciences
Mar 26, 2026
Rated: Buy
Price Target: $39 → $56
Current: $42.64
Upside: +31.33%
Valneva SE
Mar 23, 2026
Maintained: Buy
Price Target: $14 → $15
Current: $5.00
Upside: +200.00%
Feb 25, 2026
Maintained: Buy
Price Target: $28
Current: $1.82
Upside: +1,438.46%
Dec 8, 2025
Maintained: Buy
Price Target: $15 → $20
Current: $4.61
Upside: +333.84%
Nov 7, 2025
Upgraded: Buy
Price Target: $10 → $21
Current: $15.96
Upside: +31.58%
Oct 31, 2025
Downgraded: Hold
Price Target: $2 → $1.6
Current: $1.19
Upside: +34.45%
Oct 30, 2025
Maintained: Buy
Price Target: $384 → $549
Current: $267.47
Upside: +105.26%
Oct 14, 2025
Maintained: Buy
Price Target: $14 → $15
Current: $9.29
Upside: +61.46%
Oct 9, 2025
Initiated Coverage: Buy
Price Target: $41
Current: $27.53
Upside: +48.93%
Sep 10, 2025
Reiterated: Buy
Price Target: $38 → $35
Current: $56.71
Upside: -38.28%
Aug 15, 2025
Maintained: Buy
Price Target: $33 → $79
Current: $88.38
Upside: -10.61%
Aug 13, 2025
Maintained: Buy
Price Target: $40 → $23
Current: $10.73
Upside: +114.35%
Jun 24, 2025
Initiated Coverage: Hold
Price Target: $3.5
Current: $0.88
Upside: n/a
Jun 11, 2025
Maintained: Buy
Price Target: $8
Current: $5.96
Upside: n/a
May 19, 2025
Maintained: Buy
Price Target: $15 → $9
Current: $3.13
Upside: n/a
May 16, 2025
Maintained: Buy
Price Target: $7 → $15
Current: $8.72
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $2 → $1.5
Current: $0.065
Upside: n/a
Dec 6, 2024
Initiated Coverage: Buy
Price Target: $7
Current: $0.3101
Upside: n/a
Nov 13, 2024
Maintained: Buy
Price Target: $21
Current: $1.24
Upside: n/a
Oct 17, 2024
Maintained: Buy
Price Target: $25 → $31
Current: $32.13
Upside: n/a
Oct 4, 2024
Rated: Buy
Price Target: $129
Current: $29.28
Upside: n/a
Apr 4, 2024
Maintained: Buy
Price Target: $10 → $20
Current: $0.000001
Upside: n/a
Mar 13, 2024
Initiated Coverage: Buy
Price Target: $6
Current: $31.16
Upside: n/a
Feb 8, 2024
Initiated Coverage: Buy
Price Target: $15
Current: $0.966
Upside: n/a
Nov 9, 2023
Upgraded: Buy
Price Target: $6 → $26
Current: $38.50
Upside: n/a
Nov 29, 2022
Maintained: Buy
Price Target: $75
Current: $74.30
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $172 → $159
Current: $47.78
Upside: n/a
Dec 1, 2021
Downgraded: Hold
Price Target: $39 → $5
Current: $1.29
Upside: n/a
Jun 22, 2021
Maintained: Buy
Price Target: $37 → $109
Current: $11.38
Upside: n/a
Dec 21, 2020
Maintained: Hold
Price Target: $14 → $25
Current: $8.39
Upside: n/a
Jul 29, 2020
Maintained: Buy
Price Target: $34 → $86
Current: $20.20
Upside: n/a
Jun 23, 2020
Maintained: Buy
Price Target: $34 → $35
Current: $9.51
Upside: n/a
May 18, 2020
Maintained: Buy
Price Target: $25
Current: $7.87
Upside: n/a
Feb 24, 2020
Initiated Coverage: Buy
Price Target: $47
Current: $1.79
Upside: n/a
Aug 10, 2018
Reiterated: Buy
Price Target: $9 → $16
Current: $68.26
Upside: n/a
May 22, 2018
Reiterated: Buy
Price Target: $28
Current: $7.00
Upside: n/a